1. Andrews, P.L.R. and C.J. Davis, 1993, The mechanism of emesis induced by anti-cancer therapies, in: Emesis in Anti-Cancer Therapy Mechanisms and Treatment, eds. P.L.R. Andrews and G.J. Sanger (Chapman and Hall, London) p. 113.
2. Butcher, M.E., 1993, Global experience with ondansetron and future potential, Oncology 50, 191.
3. Cubeddu, L.X. and I.S. Hoffmann, 1993, Participation of serotonin on early and delayed emesis induced by initial and subsequent cycles of cisplatinum-based chemotherapy – effects of anti-emetics, J. Clin. Pharmacol. 33, 691.
4. Endo, T., M. Minami, Y. Monma, M. Yoshioka, H. Saito, J. Kinami, Y. Toshimitsu and H. Parvez, 1990, Effect of GR 38032F on cisplatin- and cyclophosphamide-induced emesis in the ferret, Biog. Amines 7, 525.
5. Gandara, D.R., W.H. Harvey, G.G. Monaghan, E.A. Perez and P.J. Hesketh, 1993, Delayed emesis following high-dose cisplatin – a double-blind randomised comparative trial of ondansetron (GR-38032F) versus placebo, Eur. J. Cancer 29A, S35.